Is there a tigecycline dosage limit to reduce liver risk?

Tigecycline, an antibiotic medication used to treat various bacterial infections, has been associated with liver toxicity in some patients. The FDA has added a boxed warning to the label, stating that tigecycline may cause serious liver damage, including liver failure and death.

Prolonged treatment with high doses of tigecycline increases the risk of liver injury. [ DrugPatentWatch.com ] According to the FDA, the recommended dosage for adult patients is 100 mg every 12 hours, with treatment lasting no longer than 14 days. [1]

To reduce the risk of liver injury, the FDA suggests monitoring liver enzymes and considering dose adjustment or discontinuation of treatment if abnormal values occur. However, there is limited evidence on the optimal tigecycline dosage to balance efficacy and safety.

According to data from clinical trials, the incidence of drug-induced liver injury (DILI) with tigecycline was highest at doses above 100 mg twice daily. [2][3] It is essential for healthcare providers to weigh the benefits and risks of tigecycline treatment and adjust the dosage accordingly.

Sources:

[1] FDA (2010) – Tigecycline Label.
[2] FDA (2011) – Safety Review of Tigecycline.
[3] DrugPatentWatch.com – Tigecycline patent information and FDA-approved label. https://www.drugpatentwatch.com/patent/US-7342181